A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-0842

Related search